0001209191-12-009621.txt : 20120213
0001209191-12-009621.hdr.sgml : 20120213
20120213180345
ACCESSION NUMBER: 0001209191-12-009621
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110822
FILED AS OF DATE: 20120213
DATE AS OF CHANGE: 20120213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Polymeropoulos Mihael Hristos
CENTRAL INDEX KEY: 0001355537
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34186
FILM NUMBER: 12600891
MAIL ADDRESS:
STREET 1: 9605 MEDICAL CENTER DRIVE SUITE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vanda Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001347178
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030491827
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9605 MEDICAL CENTER DRIVE
STREET 2: SUITE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-599-4500
MAIL ADDRESS:
STREET 1: 9605 MEDICAL CENTER DRIVE
STREET 2: SUITE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0304
4/A
2011-08-22
2011-08-24
0
0001347178
Vanda Pharmaceuticals Inc.
VNDA
0001355537
Polymeropoulos Mihael Hristos
9605 MEDICAL CENTER DRIVE
SUITE 300
ROCKVILLE
MD
20850
1
1
0
0
President and CEO
Common Stock
2011-08-22
4
P
0
2080
5.3423
A
400830
D
Common Stock
2011-08-23
4
P
0
7920
5.3476
A
408750
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.33 to $5.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 382,080 shares.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.34 to $5.35, inclusive.
The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 390,000 shares.
/s/ Mihael H. Polymeropoulos
2012-02-13